KBC Group NV - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 307 filers reported holding REPLIGEN CORP in Q4 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
KBC Group NV ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$2,9000.0%20,5030.0%0.01%0.0%
Q2 2023$2,900
-99.9%
20,503
-33.7%
0.01%
-29.4%
Q3 2019$2,372,000
+59.4%
30,929
+78.7%
0.02%
+41.7%
Q2 2019$1,488,000
+45.5%
17,3120.0%0.01%
+50.0%
Q1 2019$1,023,000
+1498.4%
17,312
+635.4%
0.01%
+700.0%
Q2 2016$64,000
+1.6%
2,3540.0%0.00%0.0%
Q1 2016$63,000
-6.0%
2,3540.0%0.00%0.0%
Q4 2015$67,000
+1.5%
2,3540.0%0.00%0.0%
Q3 2015$66,000
-54.2%
2,354
-32.7%
0.00%
-50.0%
Q2 2015$144,000
+35.8%
3,4990.0%0.00%
+100.0%
Q1 2015$106,000
+53.6%
3,4990.0%0.00%0.0%
Q4 2014$69,000
-1.4%
3,4990.0%0.00%
-50.0%
Q3 2014$70,0003,4990.00%
Other shareholders
REPLIGEN CORP shareholders Q4 2019
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders